Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and Graft-Versus-Host Disease

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Graft-Versus-Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Marini, P; Fornecker, LM; Laplace, A; Matuszak, J; Namer, IJ1
Gremmels, JM; Kirk, GA1

Other Studies

2 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Graft-Versus-Host Disease

ArticleYear
Spleen Uptake on Bone Scan After Frequent Platelet and RBC Transfusions.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:10

    Topics: Bone and Bones; Erythrocyte Transfusion; Fluorodeoxyglucose F18; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Platelet Transfusion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen; Technetium Tc 99m Medronate; Young Adult

2016
Two patients with abnormal skeletal muscle uptake of Tc-99m hydroxymethylene diphosphonate following liver transplant: nephrogenic fibrosing dermopathy and graft vs host disease.
    Clinical nuclear medicine, 2004, Volume: 29, Issue:11

    Topics: Fibrosis; Graft vs Host Disease; Humans; Kidney Diseases; Liver Transplantation; Male; Middle Aged; Muscle, Skeletal; Radionuclide Imaging; Radiopharmaceuticals; Skin Diseases; Technetium Tc 99m Medronate

2004